@cnbc: The U.S. Food and Drug Administration is requiring new safety warnings on all GLP-1 drugs after finding evidence of a potential increased risk of a rare eye condition, the agency said on Monday. ⠀ CNBC’s Annika Kim Constantino explains. ⠀ Read more at the link in bio or the link on screen. #CNBC #glp1